- The report contains detailed information about Bio Lab Naturals, Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Bio Lab Naturals, Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Bio Lab Naturals, Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Bio Lab Naturals, Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Bio Lab Naturals, Inc. business.
About Bio Lab Naturals, Inc.
Vyta Corp., through its interests in BioAgra, LLC (BioAgra), engages in the production, marketing, and sale of beta glucan feed additives for the animal feed industry.
BioAgra engages in the production, marketing and sale of Agrastim, a natural, non-toxic purified beta-1,3/1,6-D glucan feed additive used to replace growth promotion antibiotics that are used in the animal feed industry. In addition to its use as a feed additive, BioAgra intends to include Agrastim in premixed feeds, such as in EquiForce, a feed targeted for the equine industry that contains Agrastim, vitamins and minerals formulated to supply nutrients to meet the physiological needs of equine athletes and to boost their immune systems.
BioAgra is also producing Purestim, a purified beta-1,3/1,6-D glucan intended for use by other companies that manufacture neutraceuticals and dietary supplements for human consumption, and is designing other products for human, animal and aquaculture consumption based on beta glucan and other immunoenhancers. Purestim, together with Agrastim.
BioAgra is targeting a range of customers consisting of consumers of animal feed nationally and internationally. In addition, BioAgra is beginning to target neutraceutical and dietary supplement producers for the sale of Purestim as an additive in their existing products for human consumption. The company markets its products in Canada, Chile, Brazil, Japan, Vietnam, South Korea, Australia, New Zealand, Germany, Denmark, South Africa, Mexico and the United States.
In December 2007, the company sold its 49% interest in ExypnoTech, Gmbh (ExypnoTech) to TagStar Systems, GmbH. ExypnoTech is a company that manufactures and develops radio frequency identification components used in the production of, among other things, smart labels, smart cards and smart tags.
BioAgras major competitor is Fibona Health Products GmbH.
Vyta Corp was incorporated in 1996. The company was formerly known as NanoPierce Technologies, Inc., and changed its name to Vyta Corp in January 2006.
The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.
1. BIO LAB NATURALS, INC. COMPANY PROFILE
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. BIO LAB NATURALS, INC. BUSINESS OVERVIEW
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. BIO LAB NATURALS, INC. SWOT ANALYSIS
4. BIO LAB NATURALS, INC. FINANCIAL ANALYSIS
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. BIO LAB NATURALS, INC. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Bio Lab Naturals, Inc. Direct Competitors
5.2. Comparison of Bio Lab Naturals, Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Bio Lab Naturals, Inc. and Direct Competitors Stock Charts
5.4. Bio Lab Naturals, Inc. Industry Analysis
5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
5.4.2. Bio Lab Naturals, Inc. Industry Position Analysis
6. BIO LAB NATURALS, INC. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. BIO LAB NATURALS, INC. EXPERTS REVIEW1
7.1. Experts Opinion
7.2. Experts Estimates
8. BIO LAB NATURALS, INC. ENHANCED SWOT ANALYSIS2
9. UNITED STATES PESTEL ANALYSIS2
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors
10. BIO LAB NATURALS, INC. IFE, EFE, IE MATRICES2
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix
11. BIO LAB NATURALS, INC. PORTER FIVE FORCES ANALYSIS2
12. BIO LAB NATURALS, INC. VRIO ANALYSIS2
APPENDIX: RATIO DEFINITIONS
LIST OF TABLES
Bio Lab Naturals, Inc. Key Facts
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Bio Lab Naturals, Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Bio Lab Naturals, Inc. Major Shareholders
Bio Lab Naturals, Inc. History
Bio Lab Naturals, Inc. Products
Revenues by Segment
Revenues by Region
Bio Lab Naturals, Inc. Offices and Representations
Bio Lab Naturals, Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Bio Lab Naturals, Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Bio Lab Naturals, Inc. Capital Market Snapshot
Bio Lab Naturals, Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Bio Lab Naturals, Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Bio Lab Naturals, Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Revenue Estimates Trend1
Earnings Estimates Trend1
LIST OF FIGURES
Bio Lab Naturals, Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Bio Lab Naturals, Inc. 1-year Stock Charts
Bio Lab Naturals, Inc. 5-year Stock Charts
Bio Lab Naturals, Inc. vs. Main Indexes 1-year Stock Chart
Bio Lab Naturals, Inc. vs. Direct Competitors 1-year Stock Charts
Bio Lab Naturals, Inc. Article Density Chart
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.
Enhanced SWOT Analysis
- How to use the strengths to take advantage of the opportunities?
- How to use the strengths to reduce likelihood and impact of the threats?
- How to overcome the weaknesses that obstruct taking advantage of the opportunities?
- How to overcome the weaknesses that can make the threats a reality?
Key Factors Examined by PESTEL Analysis:
- Legal – What laws and legislation will exert influence on the style the business is carried out?
IFE, EFE, IE Matrices
Porter Five Forces Analysis
- What composes a threat of substitute products and services?
- Is there a threat of new competitors entering the market?
- What is the intensity of competitive rivalry?
- How big is the bargaining power of buyers?
- How significant is the bargaining power of suppliers?
- Tangible resources
- Intangible resources
- Innovation and Creativity
- Organizational capabilities
- Costly to imitate?
- Organized properly?